ThromboVision Raises $4M

Houston, Texas-based ThromboVision, said this week that it has raised $4M in a Series A convertible preferred stock financing. The investment came from National Healthcare Services and other private investors. ThromboVision is developing biomedical diagnostics products, used for preventing heart attacks, strokes, and stent occulsions. More information »